Categories Earnings, Health Care

Bausch Health Companies Inc. (NYSE: BHC): Q4 2019 Earnings Snapshot

— Bausch Health Companies Inc. (NYSE: BHC) reported a loss of $4.30 per share for the fourth quarter of 2019, compared to a loss of $0.98 per share last year, vs. $1.15 per share loss expected.

Bausch Health Companies Inc. (NYSE: BHC): Q4 2019 Earnings Snapshot

— Net loss for the quarter was $1.516 billion, compared to a loss of $344 million a year earlier

— December-quarter revenues increased 5% annually to $2.22 billion, vs. $2.2 billion expected

— Revenue of Bausch + Lomb/International, the main business segment, grew 3% annually; Salix segment revenue was up 21%

— Received FDA approval for ARAZLO Lotion for the topical treatment of acne vulgaris in young adults

— Raised capital allocation for research and development by 14% in fiscal 2019, compared to last year

— Expects full-year 2020 revenues to be in the range of $8.65 billion to $8.85 billion

— Looking for adjusted EBITDA in the range of $3.50 billion to $3.65 billion for fiscal 2020

Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text

Most Popular

Infographic: Key highlights from Constellation Brands (STZ) Q1 2023 earnings results

Constellation Brands, Inc. (NYSE: STZ) reported first quarter 2023 earnings results today. Net sales increased 17% year-over-year to $2.3 billion. Net income attributable to CBI more than doubled to $390

Walgreens Boots Alliance (WBA) Q3 profit drops on lower revenues; results beat

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Thursday said its third-quarter revenues decreased. As a result, the healthcare service company's adjusted profit declined but exceeded consensus estimates. Net profit, on

ANGO Stock: Is it the right time to invest in AngioDynamics now?

The performance of AngioDynamics, Inc. (NASDAQ: ANGO) has not been very impressive lately, despite being part of a rapidly growing industry. But the company's efforts to bring innovation to the

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top